Literature DB >> 27650070

Stroke Risk and Mortality in Patients With Ventricular Assist Devices.

Neal S Parikh1, Joséphine Cool2, Maria G Karas2, Amelia K Boehme2, Hooman Kamel2.   

Abstract

BACKGROUND AND
PURPOSE: Ventricular assist devices (VADs) have advanced the management of end-stage heart failure. However, these devices are associated with hemorrhagic and thrombotic complications, including stroke. We assessed the incidence, risk factors, and outcomes of ischemic and hemorrhagic stroke after VAD placement.
METHODS: Using administrative claims data from acute care hospitals in California, Florida, and New York from 2005 to 2013, we identified patients who underwent VAD placement, defined by the International Classification of Diseases, Ninth Revision, Clinical Modification code 37.66. Ischemic and hemorrhagic strokes were identified by previously validated coding algorithms. We used survival statistics to determine the incidence rates and Cox proportional hazard analyses to examine the associations.
RESULTS: Among 1813 patients, we identified 201 ischemic strokes and 116 hemorrhagic strokes during 3.4 (±2.0) years of follow-up after implantation of a VAD. The incidence of stroke was 8.7% per year (95% confidence interval [CI], 7.7-9.7). The annual incidence of ischemic stroke (5.5%; 95% CI, 4.8-6.4) was nearly double that of hemorrhagic stroke (3.1%; 95% CI, 2.6-3.8). Women faced a higher hazard of stroke than men (hazard ratio, 1.6; 95% CI, 1.2-2.1), particularly hemorrhagic stroke (hazard ratio, 2.2; 95% CI, 1.4-3.4). Stroke was strongly associated with subsequent in-hospital mortality (hazard ratio, 6.1; 95% CI, 4.6-7.9).
CONCLUSIONS: The incidence of stroke after VAD implantation was 8.7% per year, and incident stroke was strongly associated with subsequent in-hospital mortality. Notably, ischemic stroke occurred at nearly twice the rate of hemorrhagic stroke. Women seemed to face a higher risk for hemorrhagic stroke than men.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  heart failure; heart-assist devices; intracranial hemorrhage; risk factors; stroke

Mesh:

Year:  2016        PMID: 27650070      PMCID: PMC5079813          DOI: 10.1161/STROKEAHA.116.014049

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  36 in total

1.  Left Ventricular Ejection Fraction and Risk of Stroke and Cardiac Events in Heart Failure: Data From the Warfarin Versus Aspirin in Reduced Ejection Fraction Trial.

Authors:  Marco R Di Tullio; Min Qian; John L P Thompson; Arthur J Labovitz; Douglas L Mann; Ralph L Sacco; Patrick M Pullicino; Ronald S Freudenberger; John R Teerlink; Susan Graham; Gregory Y H Lip; Bruce Levin; J P Mohr; Richard Buchsbaum; Conrado J Estol; Dirk J Lok; Piotr Ponikowski; Stefan D Anker; Shunichi Homma
Journal:  Stroke       Date:  2016-06-28       Impact factor: 7.914

2.  Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation: Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca-Heart Failure (GISSI-HF) Trials.

Authors:  Azmil H Abdul-Rahim; Ana-Cristina Perez; Rachael L Fulton; Pardeep S Jhund; Roberto Latini; Gianni Tognoni; John Wikstrand; John Kjekshus; Gregory Y H Lip; Aldo P Maggioni; Luigi Tavazzi; Kennedy R Lees; John J V McMurray
Journal:  Circulation       Date:  2015-03-25       Impact factor: 29.690

3.  Improved Outcomes for Women on the Heart Transplant Wait List in the Modern Era.

Authors:  Alanna A Morris; Robert T Cole; S Raja Laskar; Andreas Kalogeropoulos; J David Vega; Andrew Smith; Javed Butler
Journal:  J Card Fail       Date:  2015-03-24       Impact factor: 5.712

4.  The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: executive summary.

Authors:  David Feldman; Salpy V Pamboukian; Jeffrey J Teuteberg; Emma Birks; Katherine Lietz; Stephanie A Moore; Jeffrey A Morgan; Francisco Arabia; Mary E Bauman; Hoger W Buchholz; Mario Deng; Marc L Dickstein; Aly El-Banayosy; Tonya Elliot; Daniel J Goldstein; Kathleen L Grady; Kylie Jones; Katarzyna Hryniewicz; Ranjit John; Annemarie Kaan; Shimon Kusne; Matthias Loebe; M Patricia Massicotte; Nader Moazami; Paul Mohacsi; Martha Mooney; Thomas Nelson; Francis Pagani; William Perry; Evgenij V Potapov; J Eduardo Rame; Stuart D Russell; Erik N Sorensen; Benjamin Sun; Martin Strueber; Abeel A Mangi; Michael G Petty; Joseph Rogers
Journal:  J Heart Lung Transplant       Date:  2013-02       Impact factor: 10.247

5.  Pre-operative and post-operative risk factors associated with neurologic complications in patients with advanced heart failure supported by a left ventricular assist device.

Authors:  Tomoko S Kato; P Christian Schulze; Jonathan Yang; Ernest Chan; Khurram Shahzad; Hiroo Takayama; Nir Uriel; Ulrich Jorde; Maryjane Farr; Yoshifumi Naka; Donna Mancini
Journal:  J Heart Lung Transplant       Date:  2011-10-08       Impact factor: 10.247

6.  Adverse Outcomes After Initial Non-surgical Management of Subdural Hematoma: A Population-Based Study.

Authors:  Nicholas A Morris; Alexander E Merkler; Whitney E Parker; Jan Claassen; E Sander Connolly; Kevin N Sheth; Hooman Kamel
Journal:  Neurocrit Care       Date:  2016-04       Impact factor: 3.210

7.  Intracranial hemorrhage in atrial fibrillation patients during anticoagulation with warfarin or dabigatran: the RE-LY trial.

Authors:  Robert G Hart; Hans-Christoph Diener; Sean Yang; Stuart J Connolly; Lars Wallentin; Paul A Reilly; Michael D Ezekowitz; Salim Yusuf
Journal:  Stroke       Date:  2012-04-05       Impact factor: 7.914

8.  Advanced (stage D) heart failure: a statement from the Heart Failure Society of America Guidelines Committee.

Authors:  James C Fang; Gregory A Ewald; Larry A Allen; Javed Butler; Cheryl A Westlake Canary; Monica Colvin-Adams; Michael G Dickinson; Phillip Levy; Wendy Gattis Stough; Nancy K Sweitzer; John R Teerlink; David J Whellan; Nancy M Albert; Rajan Krishnamani; Michael W Rich; Mary N Walsh; Mark R Bonnell; Peter E Carson; Michael C Chan; Daniel L Dries; Adrian F Hernandez; Ray E Hershberger; Stuart D Katz; Stephanie Moore; Jo E Rodgers; Joseph G Rogers; Amanda R Vest; Michael M Givertz
Journal:  J Card Fail       Date:  2015-05-04       Impact factor: 5.712

Review 9.  Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis.

Authors:  Charlotte Jj van Asch; Merel Ja Luitse; Gabriël Je Rinkel; Ingeborg van der Tweel; Ale Algra; Catharina Jm Klijn
Journal:  Lancet Neurol       Date:  2010-01-05       Impact factor: 44.182

10.  Fifth INTERMACS annual report: risk factor analysis from more than 6,000 mechanical circulatory support patients.

Authors:  James K Kirklin; David C Naftel; Robert L Kormos; Lynne W Stevenson; Francis D Pagani; Marissa A Miller; J T Baldwin; J Timothy Baldwin; James B Young
Journal:  J Heart Lung Transplant       Date:  2013-02       Impact factor: 10.247

View more
  11 in total

1.  Association Between Heart Transplantation and Subsequent Risk of Stroke Among Patients With Heart Failure.

Authors:  Alexander E Merkler; Monica L Chen; Neal S Parikh; Santosh B Murthy; Shadi Yaghi; Parag Goyal; Peter M Okin; Maria G Karas; Babak B Navi; Costantino Iadecola; Hooman Kamel
Journal:  Stroke       Date:  2019-03       Impact factor: 7.914

2.  Treatment course and outcomes after revascularization surgery for moyamoya disease in adults.

Authors:  Amanda Kahn; Gurmeen Kaur; Laura Stein; Stanley Tuhrim; Mandip S Dhamoon
Journal:  J Neurol       Date:  2018-09-08       Impact factor: 4.849

3.  Response by Parikh and Kamel to Letter Regarding Article, "Stroke Risk and Mortality in Patients With Ventricular Assist Devices".

Authors:  Neal S Parikh; Hooman Kamel
Journal:  Stroke       Date:  2016-11-29       Impact factor: 7.914

4.  Implications of Causes of Intracranial Hemorrhage During Left Ventricular Assist Device Support.

Authors:  Aaron Shoskes; Catherine Hassett; Aron Gedansky; Randall Carson Starling; Jerry D Estep; Michael Z Y Tong; Sung-Min Cho; Ken Uchino
Journal:  Neurocrit Care       Date:  2022-04-12       Impact factor: 3.532

5.  Gastrointestinal Bleeding as a Complication in Continuous Flow Ventricular Assist Devices: A Systematic Review With Meta-Analysis.

Authors:  Edinen Asuka; Stella Pak; Armond-Kristopher Thiess; Anthony Torres
Journal:  J Clin Med Res       Date:  2020-08-15

6.  Incidence and impact of ischemic and hemorrhagic stroke after left ventricular assist device implantation: A nationwide study.

Authors:  Samarthkumar Thakkar; Chintan Rupareliya; Rajkumar Doshi
Journal:  Indian Heart J       Date:  2019-09-13

7.  Characteristics of strokes associated with centrifugal flow left ventricular assist devices.

Authors:  Ovais Inamullah; Yuting P Chiang; Muath Bishawi; Martin Weiss; Michael W Lutz; Laura J Blue; Wayne Feng; Carmelo A Milano; Matthew Luedke; Nada El Husseini
Journal:  Sci Rep       Date:  2021-01-18       Impact factor: 4.379

8.  Stroke Incidence and Impact of Continuous-Flow Left Ventricular Assist Devices on Cerebrovascular Physiology.

Authors:  William K Cornwell; Amrut V Ambardekar; Tomio Tran; Jay D Pal; Luis Cava; Justin Lawley; Takashi Tarumi; Christy L Cornwell; Keith Aaronson
Journal:  Stroke       Date:  2019-02       Impact factor: 7.914

9.  Intermediate-Term Risk of Stroke Following Cardiac Procedures in a Nationally Representative Data Set.

Authors:  Laura Stein; Alison Thaler; John W Liang; Stanley Tuhrim; Amit S Dhamoon; Mandip S Dhamoon
Journal:  J Am Heart Assoc       Date:  2017-12-02       Impact factor: 5.501

Review 10.  Antithrombotic therapy in ventricular assist device (VAD) management: From ancient beliefs to updated evidence. A narrative review.

Authors:  Nuccia Morici; Marisa Varrenti; Dario Brunelli; Enrico Perna; Manlio Cipriani; Enrico Ammirati; Maria Frigerio; Marco Cattaneo; Fabrizio Oliva
Journal:  Int J Cardiol Heart Vasc       Date:  2018-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.